Microbix Biosystems Inc
TSX:MBX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Microbix Biosystems Inc
TSX:MBX
|
CA |
|
R
|
Radiant Cash Management Services Ltd
NSE:RADIANTCMS
|
IN |
|
Cape Range Ltd
ASX:CAG
|
AU |
|
Toyokumo Inc
TSE:4058
|
JP |
|
Vivesto AB
STO:VIVE
|
SE |
|
C
|
Core Assets Corp
CNSX:CC
|
CA |
|
N
|
Nickel Asia Corp
XPHS:NIKL
|
PH |
|
Broendbyernes IF Fodbold A/S
CSE:BIF
|
DK |
|
Atco Ltd
TSX:ACO.X
|
CA |
|
Quadient SA
F:NEQ
|
FR |
Wall Street
Price Targets
MBX Price Targets Summary
Microbix Biosystems Inc
According to Wall Street analysts, the average 1-year price target for
MBX
is 0.51 CAD
with a low forecast of 0.505 CAD and a high forecast of 0.525 CAD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MBX's stock price target?
Price Target
0.51
CAD
According to Wall Street analysts, the average 1-year price target for
MBX
is 0.51 CAD
with a low forecast of 0.505 CAD and a high forecast of 0.525 CAD.
What is Microbix Biosystems Inc's Revenue forecast?
Projected CAGR
57%
For the last 13 years the
compound annual growth rate for
Microbix Biosystems Inc's revenue is
8%.
The projected
CAGR
for the next 2 years is
57%.
